Delivery Order SPE2DB24D1034-SPE2DB25FWAF6
Award Date
2/4/25
Potential Completion Date
2/5/25
Potential Value
$3.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DB22D1017|SPE2DB25FF5PX, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,146.57 Firm Fixed Price Delivery Order contract is for the supply of 4567292573 - RISPERIDONE 3 MG TABLET 60S, with a performance period through February 19, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of Risperdal 2 mg tablets. The award, valued at $1,536.79, is a firm fixed-price delivery order with an ultimate completion date of January 4, 2024. Amerisourcebergen is a subsidiary of Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through...
This is a federal delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) to supply Risperdal 4 mg tablets. The contract has a total ceiling value of $18,809.91 and a period of performance through October 25, 2024. It is a firm-fixed-price delivery order contract, with no set-aside designation, indicating open competition. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $2,879.18, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RISPERDAL CONSTA 37.5 MG VIALS, a specialty medication. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of August 15, 2024. The contract was not set aside for any specific business type. AmerisourceBergen holds a significant...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Risperdal 2 mg tablets to the Defense Logistics Agency (DLA). The firm-fixed-price, $10,348.17 delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,190.76, is for the delivery of 4566343159 - Risperidone 0.5 mg Tablets, 60 count, to support military healthcare programs. The contract is a Delivery Order with a Firm Fixed Price pricing type, with a final completion date of November 6, 2024. The award is not associated with...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $4,056.73, is for the delivery of the pharmaceutical product Risperdal 3 mg tablets. The IDC has a ceiling value of $999,999,999 and runs through November 2026, providing a comprehensive vehicle for the company to supply a range of pharmaceutical products and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,644.11 firm-fixed-price delivery order contract is for the supply of 500 units of the medication Risperidone 2 mg tablet. The contract has an ultimate completion date of February 9, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999.00...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $2,933.50 under a larger Indefinite Delivery Contract (IDC) held with the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of 4564515074 RISPERDAL 1 MG TABLET 60S, a pharmaceutical product, with a completion date of May 7, 2024. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $5,977.48, is for the delivery of Risperdal 4 mg tablets. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to...